Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Hoffmann-la Roche

Clinical trials sponsored by Hoffmann-la Roche, explained in plain language.

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 24 Completed 14 Terminated 2
Sort by
  • Lung cancer immunotherapy combo trial halted early

    Disease control Terminated

    This study looked at whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after surgery, with or without chemotherapy, is safe and effective for people with a certain type of lung cancer (stage II-IIIB non-small cell lung cancer) that can be removed su…

    Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

    Last updated Apr 29, 2026 02:24 UTC

  • Dup15q drug trial halted early: what we know

    Disease control Terminated

    This study tested a drug called basmisanil in children aged 2 to 14 with Dup15q syndrome, a rare genetic condition that affects development. The goal was to see if the drug could improve daily living skills like communication and movement. The trial was stopped early, and only 7 …

    Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

    Last updated Apr 28, 2026 13:02 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space